Dynavax Technologies Corp. (DVAX)

6.54
0.06 0.91
NASDAQ : Health Technology
Prev Close 6.60
Open 6.55
Day Low/High 6.49 / 6.90
52 Wk Low/High 2.60 / 12.42
Volume 1.14M
Avg Volume 1.19M
Exchange NASDAQ
Shares Outstanding 83.87M
Market Cap 552.67M
EPS -2.50
P/E Ratio N/A
Div & Yield N.A. (N.A)

Futures Are Higher As Jobs Report Hits

Premarket futures are still pointing to a higher opening as we get the January U.S. jobs report. It's going to be interesting to see how the market reacts to the numbers. At this point, I don't know what would be better for stocks. A strong report w...

Buy These Biotechs Before They Bounce

Buy These Biotechs Before They Bounce

Here are some mid-cap names with solid upside potential.

How to Build a Good Foundation in Biotechs

How to Build a Good Foundation in Biotechs

A so-called "pyramid strategy" can help you enter the depressed sector.

My Wall Street Fantasy Football League

My Wall Street Fantasy Football League

If there were a Super Bowl for stocks, these companies could win.

So-So Start, But GoPro Is Going Higher

The market is off to a tepid start after rallying for three straight days -- certainly understandable, and some profit taking should be expected as we trade up near the highs of the relatively narrow trading range that has existed throughout most of...

Dynavax: Revisiting A 'Best Idea'

Dynavax: Revisiting A 'Best Idea'

This small-cap biotech firm could be in the early stages of a big move.

Check in to Diamondrock Hospitality

Check in to Diamondrock Hospitality

Anatomy of a solid lodging REIT.

How I Play the Biotechs

How I Play the Biotechs

A strategy to immunize biotech investors from regret.

Biotech Is Getting Frothy

The market opened on a very strong note and Biogen Idec is up big after announcing study of its experimental drug for Alzheimer's disease had exceeded expectations.  The whole biotech sector is having another strong day after yesterday's huge outper...

Dynavax Technologies: A New 'Best Idea'

Dynavax Technologies: A New 'Best Idea'

This vaccine maker is now closer to several important milestones.

Three Small Caps for 2015

Three Small Caps for 2015

For these three, the New Year looks bright.

Biotech Holding Up

But looks like the second-worst weekly loss of the year. The market continues to post losses across the board, but is off the lows of the day.  Looks like equities are heading to their second-worst weekly loss of the year. The 10 year Treasuries loo...

Some Stocks to Watch Today

Though broad futures have improved somewhat. Market futures are still pointing to a down open, but they have improved somewhat since my first Diary post this morning. Meantime, oil just can't get any love. The International Energy Agency (IEA) has c...

Agenus: A Promising Biotech Play

Agenus: A Promising Biotech Play

Approval of malaria vaccine could provide a shot in the arm.

A Biotech With Enormous Potential

A Biotech With Enormous Potential

The market seems to be severely discounting DynaVax's chances of approval for its hep-B treatment.

Invest in a Healthy Liver

Invest in a Healthy Liver

Drugs for liver diseases are good opportunities.

The Market's 'March Madness' Underdogs

The Market's 'March Madness' Underdogs

These small-cap names could cause some big upsets.

Two Small-Cap Biotechs to Watch

Two Small-Cap Biotechs to Watch

The sector is not for the investor who abhors volatility.

The Next Big Thing in Biotech: Dynavax

The Next Big Thing in Biotech: Dynavax

Senior columnist Adam Feuerstein says Dynavax Technologies is the next big thing to watch in biotech.